Found: 160
Select item for more details and to access through your institution.
Seismic survey in urban area: the activities of the EMERSITO INGV emergency group in Ancona (Italy) following the 2022 M<sub>W</sub> 5.5 Costa Marchigiana-Pesarese earthquake.
- Published in:
- Earth System Science Data Discussions, 2024, p. 1, doi. 10.5194/essd-2024-162
- By:
- Publication type:
- Article
Health-Related Quality of Life in Psoriasis: Literature Review.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 16, p. 4623, doi. 10.3390/jcm13164623
- By:
- Publication type:
- Article
649 - Safety of tralokinumab for the treatment of atopic dermatitis in patients with up to 4.5 years of treatment: an updated integrated analysis of eight clinical trials.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.028
- By:
- Publication type:
- Article
734 - Efficacy and safety of upadacitinib vs dupliumab in adults and adolescents with moderate-to-severe atopic dermatitis: results of an open-label, efficacy assessor-blinded head-to-head phase 3b/4 study (Level Up).
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.107
- By:
- Publication type:
- Article
Thin Amelanotic and Hypomelanotic Melanoma: Clinicopathological and Dermoscopic Features.
- Published in:
- Medicina (1010660X), 2024, v. 60, n. 8, p. 1239, doi. 10.3390/medicina60081239
- By:
- Publication type:
- Article
Effectiveness of ixekizumab for the treatment of moderate‐to‐severe plaque psoriasis with involvement of difficult‐to‐treat areas: A 52‐week multicenter retrospective study.
- Published in:
- Journal of Dermatology, 2024, v. 51, n. 6, p. 839, doi. 10.1111/1346-8138.17115
- By:
- Publication type:
- Article
OPT-In; Optimized Patient Treatment Outcomes in Plaque Psoriasis: A 3-Year State-Transition Treatment-Sequencing Model in the Italian Setting.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 5, p. 1273, doi. 10.1007/s13555-024-01170-8
- By:
- Publication type:
- Article
Baseline Characteristics and mNAPSI Change from Baseline Scores Through Month 12 for Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with Biologics from PSoHO.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 5, p. 1327, doi. 10.1007/s13555-024-01150-y
- By:
- Publication type:
- Article
Atypical facial pustular folliculitis by Klebsiella pneumoniae: a case report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 4, p. 919, doi. 10.1007/s13555-024-01135-x
- By:
- Publication type:
- Article
Atypical facial pustular folliculitis by Klebsiella pneumoniae: a case report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial.
- Published in:
- American Journal of Clinical Dermatology, 2024, v. 25, n. 2, p. 315, doi. 10.1007/s40257-023-00816-1
- By:
- Publication type:
- Article
Practical Use of Upadacitinib in Patients with Severe Atopic Dermatitis in a Real-World Setting: A Systematic Review.
- Published in:
- Clinical, Cosmetic & Investigational Dermatology, 2024, v. 17, p. 593, doi. 10.2147/CCID.S329442
- By:
- Publication type:
- Article
Rapid skin clearance and itch improvement with upadacitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: results from a phase 3b head-to-head clinical trial (Heads Up).
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii30, doi. 10.1093/bjd/ljad498.033
- By:
- Publication type:
- Article
Safety of tralokinumab for the treatment of atopic dermatitis in patients with up to 4.5 years of treatment: an updated integrated analysis of eight clinical trials.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii52, doi. 10.1093/bjd/ljad498.054
- By:
- Publication type:
- Article
Effectiveness and Safety of Biological Therapies in Very Severe Plaque Psoriasis: A Real-Life Retrospective Study.
- Published in:
- Journal of Personalized Medicine, 2024, v. 14, n. 2, p. 186, doi. 10.3390/jpm14020186
- By:
- Publication type:
- Article
Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses - IL PSO (Italian landscape psoriasis).
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2023.1341708
- By:
- Publication type:
- Article
Methotrexate-Induced Mucositis in a Patient With Angioimmunoblastic T-cell Lymphoma.
- Published in:
- Cutis, 2024, v. 113, n. 1, p. 1, doi. 10.12788/cutis.0956
- By:
- Publication type:
- Article
A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks.
- Published in:
- Dermatology Reports, 2024, v. 16, n. 1, p. 16, doi. 10.4081/dr.2023.9722
- By:
- Publication type:
- Article
Effectiveness and safety of risankizumab in HIV patients with psoriasis: A case series.
- Published in:
- International Journal of STD & AIDS, 2024, v. 35, n. 1, p. 67, doi. 10.1177/09564624231199510
- By:
- Publication type:
- Article
Urban Seismic Networks: A Worldwide Review.
- Published in:
- Applied Sciences (2076-3417), 2023, v. 13, n. 24, p. 13165, doi. 10.3390/app132413165
- By:
- Publication type:
- Article
Safety of Interleukin Inhibitors in Patients with Plaque Psoriasis and Neoplasm: A Retrospective Study from Two Referral Centers.
- Published in:
- Clinical Drug Investigation, 2023, v. 43, n. 10, p. 807, doi. 10.1007/s40261-023-01306-2
- By:
- Publication type:
- Article
Tildrakizumab improves high burden skin symptoms, impaired sleep and quality of life of moderate‐to‐severe plaque psoriasis patients in conditions close to clinical practice.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 10, p. 2004, doi. 10.1111/jdv.19229
- By:
- Publication type:
- Article
Safety profile of risankizumab in the treatment of psoriasis patients with concomitant hepatitis B or C infection: A multicentric retrospective cohort study of 49 patients.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 10, p. e1203, doi. 10.1111/jdv.19186
- By:
- Publication type:
- Article
Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study.
- Published in:
- Dermatology Reports, 2023, v. 15, n. 3, p. 1, doi. 10.4081/dr.2023.9692
- By:
- Publication type:
- Article
Efficacy of baricitinib 4 mg in patients with moderate‐to‐severe atopic dermatitis previously treated with systemic therapy.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 583, doi. 10.1002/jvc2.187
- By:
- Publication type:
- Article
Baseline Body Surface Area and Itch Severity Define Response to Baricitinib in Patients with Moderate-to-Severe Atopic Dermatitis at Week 16.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 8, p. 3574, doi. 10.1007/s12325-023-02528-8
- By:
- Publication type:
- Article
Multiple facial angiofibromas: A manifestation of Frank‐ter Haar syndrome?
- Published in:
- American Journal of Medical Genetics. Part A, 2023, v. 191, n. 8, p. 2249, doi. 10.1002/ajmg.a.63231
- By:
- Publication type:
- Article
Cutaneous toxicity of CAR T‐cell therapy: Case report of a bullous life‐threatening reaction.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 6, p. e729, doi. 10.1111/jdv.18892
- By:
- Publication type:
- Article
Nonadherence to immune-modifying therapies during the COVID-19 pandemic: the crucial role of doctor–patient communication in avoiding drug discontinuation.
- Published in:
- British Journal of Dermatology, 2023, v. 188, n. 5, p. 586, doi. 10.1093/bjd/ljad014
- By:
- Publication type:
- Article
Intra-Class Switch Among IL-23 Inhibitors for Plaque Psoriasis: Is It Worth It?
- Published in:
- Clinical Drug Investigation, 2023, v. 43, n. 5, p. 365, doi. 10.1007/s40261-023-01271-w
- By:
- Publication type:
- Article
Secukinumab demonstrates superiority over narrow‐band ultraviolet B phototherapy in new‐onset moderate to severe plaque psoriasis patients: Week 52 results from the STEPIn study.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 5, p. 1004, doi. 10.1111/jdv.18846
- By:
- Publication type:
- Article
Factors Predicting Quality of Life Impairment in Adult Patients with Atopic Dermatitis: Results from a Patient Survey and Machine Learning Analysis.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 4, p. 981, doi. 10.1007/s13555-023-00897-0
- By:
- Publication type:
- Article
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study.
- Published in:
- Vaccines, 2023, v. 11, n. 4, p. 740, doi. 10.3390/vaccines11040740
- By:
- Publication type:
- Article
Distinct Neuropsychological Correlates of Apathy Sub-Domains in Multiple Sclerosis.
- Published in:
- Brain Sciences (2076-3425), 2023, v. 13, n. 3, p. 385, doi. 10.3390/brainsci13030385
- By:
- Publication type:
- Article
Efficacy and safety of switching psoriatic patients to bimekizumab: new evidence from clinical trials.
- Published in:
- British Journal of Dermatology, 2023, v. 188, n. 3, p. 316, doi. 10.1093/bjd/ljac133
- By:
- Publication type:
- Article
Monkeypox infection with perianal lesions, fever, and lymphadenopathy.
- Published in:
- International Journal of Dermatology, 2023, v. 62, n. 3, p. e142, doi. 10.1111/ijd.16437
- By:
- Publication type:
- Article
Long-Term Sequential Digital Dermoscopy of Low-Risk Patients May Not Improve Early Diagnosis of Melanoma Compared to Periodical Handheld Dermoscopy.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1129, doi. 10.3390/cancers15041129
- By:
- Publication type:
- Article
309 Tralokinumab demonstrated a consistent safety profile with up to 42 months of treatment in moderate-to-severe atopic dermatitis: including adverse events of special interest.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. ii6, doi. 10.1093/bjd/ljac140.009
- By:
- Publication type:
- Article
332 Improvement in symptoms of atopic dermatitis (AD) and AD-related quality of life with dupilumab treatment in adults: 24-week results of the DUPISTAD study.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. ii21, doi. 10.1093/bjd/ljac140.027
- By:
- Publication type:
- Article
335 Improvement in sleep quality, anxiety and depression in adults with moderate-to-severe atopic dermatitis with dupilumab treatment.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. ii23, doi. 10.1093/bjd/ljac140.029
- By:
- Publication type:
- Article
Real-Life Effectiveness and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Single-Center 16-Week Study.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 2, p. 651, doi. 10.1007/s13555-022-00882-z
- By:
- Publication type:
- Article
Co-Creating GIS-Based Dashboards to Democratize Knowledge on Urban Resilience Strategies: Experience with Camerino Municipality.
- Published in:
- ISPRS International Journal of Geo-Information, 2023, v. 12, n. 2, p. 65, doi. 10.3390/ijgi12020065
- By:
- Publication type:
- Article
Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study—IL PSO (Italian landscape psoriasis).
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 1, p. 93, doi. 10.1111/jdv.18594
- By:
- Publication type:
- Article
Sub‐erythrodermic psoriasis successfully treated with bimekizumab: A case report.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15952
- By:
- Publication type:
- Article
Laser Scanning Investigation and Geophysical Monitoring to Characterise Cultural Heritage Current State and Threat by Traffic-Induce Vibrations: The Villa Farnesina in Rome.
- Published in:
- Remote Sensing, 2022, v. 14, n. 22, p. 5818, doi. 10.3390/rs14225818
- By:
- Publication type:
- Article
ImmUniverse Consortium: Multi-omics integrative approach in personalized medicine for immune-mediated inflammatory diseases.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.1002629
- By:
- Publication type:
- Article
Complete response of locally advanced cutaneous squamous cell carcinoma of the eyelid to topical imiquimod 3.75%.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 11, p. 1, doi. 10.1111/dth.15800
- By:
- Publication type:
- Article
Comparative effectiveness of biologics in clinical practice: week 12 primary outcomes from an international observational psoriasis study of health outcomes (PSoHO).
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2022, v. 36, n. 11, p. 2087, doi. 10.1111/jdv.18376
- By:
- Publication type:
- Article
Cutaneous localisation of Hodgkin lymphoma resembling hard-to-heal graft-versus-host disease skin ulcers: a tricky mimic.
- Published in:
- 2022
- By:
- Publication type:
- Case Study